참고문헌
- Artuc M, Steckelings M, Henz BM (2002). Mast cell–fibroblast interactions: human mast cells as source and inducer of fibroblast and epithelial growth factors. J Invest Dermatol, 118, 391-5. https://doi.org/10.1046/j.0022-202x.2001.01705.x
- Cheema VS, Ramesh V, Balamurali PD (2012). The relevance of mast cells in oral squamous cell carcinoma. J Clin Diagn Res, 6, 1803-7.
- Ch'ng S, Wallis RA, Yuan L, Davis PF, Tan ST (2006). Mast cells and cutaneous malignancies. Mod Pathol, 19, 149-59.
- Coussens LM, Raymond WW, Bergers G, et al (1999). Inflammatory mast cells up- regulates angiogenesis during squamous epithelial carcinogenesis. Genes Dev, 13, 1382-97. https://doi.org/10.1101/gad.13.11.1382
- Elpek G, Gelen T (2001). The prognostic relevance of angiogenesis and mast cells in SCC of the esophagus. J Clin Pathol, 54, 940-4. https://doi.org/10.1136/jcp.54.12.940
- Fukushima H, Ohsawa M, Ikura Y, et al (2006). Mast cells in diffuse large B-cell lymphoma; their role in fibrosis. Histopathology, 49, 498-505. https://doi.org/10.1111/j.1365-2559.2006.02534.x
- Galli SJ, Kalesnikoff J, Grimbaldeston MA, et al (2005). Mast cells as “tunable” effector and immunoregulatory cells: Recent advances. Annu Rev Immunol, 23, 749-86. https://doi.org/10.1146/annurev.immunol.21.120601.141025
- Galli SJ, Nakae S, Tsai M (2005). Mast cells in the development of adaptive immune responses. Nat Immunol, 6, 135-42. https://doi.org/10.1038/ni1158
- Hogan AD, Schwartz LB (1997). Markers of mast cell degranulation. Method, 13, 43-52. https://doi.org/10.1006/meth.1997.0494
- Iamaroon A, Surawut P, Sumana J (2003). Increase of mast cell and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med, 32, 195-9. https://doi.org/10.1034/j.1600-0714.2003.00128.x
- Jaafari-Ashkavandi Z, Moshref M, Mashhadi-Abbas F, Sargolzaie S, Taghavi N (2010). Evaluation of CD31 expression and mast cell count in dysplastic lesions and squamous cell carcinoma of the oral cavity. Iran Red Crescent Med J, 12, 272-6
- Messadi DV, Wilder-Smith P, Wolinsky L (2009). Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc, 37, 789-98.
- Nechushtan H (2010). The complexity of the complicity of mast cells in cancer. Int J Biochem Cell Biol, 42, 551-4 https://doi.org/10.1016/j.biocel.2009.12.015
- Norrby K (2002). Mast cell and angiogenesis. APMIS, 110, 355-71. https://doi.org/10.1034/j.1600-0463.2002.100501.x
- Oliveira-Neto HH, Leite AF, Costa NL, et al (2007). Decrease in mast cells in oral squamous cell carcinoma: possible failure in the migration of these cells. Oral Oncol, 43, 484-90. https://doi.org/10.1016/j.oraloncology.2006.05.004
- Rajput AB, Turbin DA, Cheang MC, et al (2008). Stromal mast cells in invasive breast cancer are a marker of favorable prognosis: a study of 4,444 cases. Breast Cancer Res Treat, 107, 249-57. https://doi.org/10.1007/s10549-007-9546-3
- Ribatti D, Crivellato E (2009). The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol, 275, 89-131. https://doi.org/10.1016/S1937-6448(09)75004-X
- Ribatti D, Ennas MG, Vacca A, et al (2003). Tumor vascularity and tryptase positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest, 33, 420-5. https://doi.org/10.1046/j.1365-2362.2003.01152.x
- Rojas IG, Spencer ML, Martinez SL, et al (2005). Characterization of mast cells subpopulation in lip cancer. J Oral Path Med, 34, 268-273. https://doi.org/10.1111/j.1600-0714.2004.00297.x
- Rueff F, Przybilla B, Bilo MB, et al (2010). Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol, 126, 105-11. https://doi.org/10.1016/j.jaci.2010.04.025
- Samoszuk M, Corwin MA (2003). Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer. Int J Cancer, 107, 159-63. https://doi.org/10.1002/ijc.11340
- Sayed BA, Christy A, Quirion MR, Brown MA (2008). The master switch: The role of mast cells in autoimmunity and tolerance. Annu Rev Immunol, 26, 705-39. https://doi.org/10.1146/annurev.immunol.26.021607.090320
- Sperr WR, Jordan JH, Baghestanian M, et al (2001). Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood, 98, 2200-9. https://doi.org/10.1182/blood.V98.7.2200
- Strouch MJ, Cheon EC, Salabat MR, et al (2010). Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res, 16, 2257-65. https://doi.org/10.1158/1078-0432.CCR-09-1230
- Tayebi-Meybodi N, Javidi Z, Esmaili HA, Nahidi Y (2007). Mast cells and histopathologic variants of basal cell carcinoma. Iran J Dermatol, 10, 135-41.
- Tinge B, Molin D, Bergqvist M, Ekman S, Bergstrom S (2010). Mast cells in squamous cell esophageal carcinoma and clinical parameters. Cancer Genomics Proteomics, 7, 25-9.
- Valent P, Horny HP, Triggiani M, Arock M (2011). Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria. Int Arch Allergy Immunol, 156, 119-27. https://doi.org/10.1159/000323763
- Xiang M, Gu Y, Zhao F, et al (2020). Mast cell tryptase promotes breast cancer migration and invasion. Oncol Rep, 23, 615-9.
피인용 문헌
- The serum tryptase test: an emerging robust biomarker in clinical hematology vol.7, pp.5, 2014, https://doi.org/10.1586/17474086.2014.955008